Long-term safety and efficacy of add-on cannabidiol for treatment of seizures associated with tuberous sclerosis complex in an open-label extension

被引：0
|
作者：
Kwan, Patrick [1 ,2 ]
Thiele, Elizabeth A. [3 ]
Bebin, E. Martina [4 ]
Filloux, Francis [5 ]
Jansen, Floor E. [6 ]
Loftus, Rachael [7 ]
Sahebkar, Farhad [8 ]
Sparagana, Steven [9 ,10 ]
Wheless, James [11 ,12 ]
机构：
[1] Monash Univ, Melbourne, Vic, Australia
[2] Univ Melbourne, Melbourne, Vic, Australia
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
[4] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA
[5] Univ Utah, Sch Med, Salt Lake City, UT USA
[6] Univ Med Ctr, Brain Ctr, Utrecht, Netherlands
[7] GW Res Ltd, Cambridge, England
[8] Greenwich Biosci Inc, Carlsbad, CA USA
[9] Scottish Rite Children, Dallas, TX USA
[10] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[11] Univ Tennessee, Hlth Sci Ctr, Memphis, TN 38163 USA
[12] Le Bonheur Childrens Hosp, Memphis, TN USA
来源：
EPILEPSIA | 2021年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
135
引用
收藏
页码：145 / 146
页数：2
相关论文
共 50 条
  • [31] Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study
    Gevaert, Philippe
    Saenz, Rebecca
    Corren, Jonathan
    Han, Joseph K.
    Mullol, Joaquim
    Lee, Stella E.
    Ow, Randall A.
    Zhao, Rui
    Howard, Monet
    Wong, Kit
    Islam, Lutaf
    Ligueros-Saylan, Monica
    Omachi, Theodore A.
    Bachert, Claus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (03) : 957 - +
  • [32] Long-term seizure freedom in patients with partial seizures treated with add-on pregabalin: Analysis of open-label studies
    Uthman, B.
    Bazil, C.
    Griesing, T.
    Whalen, E.
    Spiegel, K.
    Barrett, J.
    EPILEPSIA, 2006, 47 : 144 - 144
  • [33] Maintenance of long-term efficacy and safety of quetiapine in the open-label treatment of schizophrenia
    Kasper, S
    Brecher, M
    Fitton, L
    Jones, AM
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2004, 19 (05) : 281 - 289
  • [34] Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: results from the DAYBREAK open-label extension study
    Steinman, L.
    Comi, G.
    Bar-Or, A.
    Selmaj, K. W.
    Arnold, D. L.
    Hartung, H. -P.
    Montalban, X.
    Havrdova, E. K.
    Sheffield, J. K.
    Minton, N.
    Janjua, A.
    Huang, V.
    Silva, D.
    Kappos, L.
    Cohen, J. A.
    Cree, B. A. C.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 548 - 549
  • [35] Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: interim analysis of the DAYBREAK open-label extension study
    Selmaj, K. W.
    Steinman, L.
    Comi, G.
    Bar-Or, A.
    Arnold, D. L.
    Hartung, H. -P.
    Montalban, X.
    Havrdova, K.
    Hoogerheyde, J.
    Afsari, S.
    Sheffield, J. K.
    Shi, F.
    Minton, N.
    Silva, D.
    Kappos, L.
    Cohen, J. A.
    Cree, B. A. C.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 617 - 618
  • [36] Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: interim analysis of the DAYBREAK open-label extension study
    Selmaj, K. W.
    Steinman, L.
    Comi, G.
    Bar-Or, A.
    Arnold, D. L.
    Hartung, H. -P.
    Montalban, X.
    Havrdova, E. K.
    Krakovich, A.
    Sheffield, J. K.
    Cheng, C. -Y.
    Minton, N.
    Silva, D.
    Kappos, L.
    Cohen, J. A.
    Cree, B. A. C.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 359 - 360
  • [37] A Cost-Utility Analysis of Add-On Cannabidiol Versus Usual Care Alone for the Treatment of Seizures Associated with Tuberous Sclerosis Complex in England and Wales
    Burke, Colin
    Crossan, Catriona
    Tyas, Emma
    Hemstock, Matthew
    Lee, Dawn
    Bowditch, Sally
    PHARMACOECONOMICS-OPEN, 2024, 8 (04) : 611 - 626
  • [38] PULSAR Open-Label Extension: Long-Term Efficacy and Safety of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)
    Humbert, M.
    Mclaughlin, V. V.
    Gibbs, S. R.
    Gomberg-Maitland, M.
    Hoeper, M.
    Preston, I. R.
    Souza, R.
    Waxman, A. B.
    Ghofrani, H. A.
    Subias, P. Escribano
    Feldman, J. P.
    Bohns Meyer, G.
    Montani, D.
    Olsson, K. M.
    Manimaran, S.
    Pena, J. de Oliveira
    Badesch, D. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [39] Prospective, open-label, long-term study on levetiracetam add-on treatment in patients with refractory partial epilepsy
    Boero, G.
    Specchio, N.
    Stuppiello, M.
    Papantonio, A.
    De Agazio, G.
    De Palo, A.
    Sinisi, V.
    Santosabato, M.
    La Neve, A.
    Specchio, L. M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 228 - 229
  • [40] Long-term Efficacy and Safety of Adjunctive Cenobamate in Patients With Uncontrolled Focal Seizures: Open-label Extension of a Randomized Clinical Study
    Klein, Pavel
    Krauss, Gregory
    Aboumatar, Sami
    Kamin, Marc
    NEUROLOGY, 2020, 94 (15)
12345